Your browser doesn't support javascript.
loading
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
Piette, C; Suciu, S; Clappier, E; Bertrand, Y; Drunat, S; Girard, S; Yakouben, K; Plat, G; Dastugue, N; Mazingue, F; Grardel, N; van Roy, N; Uyttebroeck, A; Costa, V; Minckes, O; Sirvent, N; Simon, P; Lutz, P; Ferster, A; Pluchart, C; Poirée, M; Freycon, C; Dresse, M-F; Millot, F; Chantrain, C; van der Werff Ten Bosch, J; Norga, K; Gilotay, C; Rohrlich, P-S; Benoit, Y; Cavé, H.
Afiliação
  • Piette C; University Department of Pediatrics, Pediatric Onco-Hematology, CHR Citadelle, Liège, Belgium.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • Clappier E; Département de Génétique, Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Bertrand Y; Institut Universitaire d'Hématologie, Université Paris Diderot, Paris-Sorbonne-Cité, Paris, France.
  • Drunat S; Department of Pediatric Hematology, IHOP, Hospices Civils de Lyon and Claude Bernard Lyon University, Lyon, France.
  • Girard S; Département de Génétique, Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Yakouben K; Laboratory of Hematology, East Lyon University Hospital, Hospices Civils de Lyon, Lyon, France.
  • Plat G; Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Service d'Immuno-Hématologie pédiatrique, Paris, France.
  • Dastugue N; Department of Pediatric Onco-Hematology, Purpan University Hospital, Toulouse, France.
  • Mazingue F; Department of Pediatric Onco-Hematology, Purpan University Hospital, Toulouse, France.
  • Grardel N; Department of Pediatric Hematology-Oncology, Lille University Hospital, Lille, France.
  • van Roy N; Department of Pediatric Hematology-Oncology, Lille University Hospital, Lille, France.
  • Uyttebroeck A; Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • Costa V; Department of Pediatrics, University Hospital Gasthuisberg, Leuven, Belgium.
  • Minckes O; Department of Pediatrics, Portuguese Oncology Institute, Porto, Portugal.
  • Sirvent N; Department of Pediatric Onco-Hematology, Caen University Hospital, Caen, France.
  • Simon P; Department of Pediatric Onco-Hematology, Montpellier University Hospital, Montpellier, France.
  • Lutz P; Department of Pediatric Onco-Hematology, Besançon University Hospital, Besançon, France.
  • Ferster A; Department of Hematology, Hautepierre University Hospital, Strasbourg, France.
  • Pluchart C; Department of Pediatric Onco-Hematology, Hôpital Universitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.
  • Poirée M; Department of Pediatric Onco-Hematology, Reims University Hospital, Reims, France.
  • Freycon C; Department of Pediatric Onco-Hematology, Nice University Hospital, Nice, France.
  • Dresse MF; Department of Pediatric Onco-Hematology, Grenoble University Hospital, Grenoble, France.
  • Millot F; University Department of Pediatrics, Pediatric Onco-Hematology, CHR Citadelle, Liège, Belgium.
  • Chantrain C; Department of Pediatric Onco-Hematology, Poitiers University Hospital, Poitiers, France.
  • van der Werff Ten Bosch J; Department of Pediatrics, Clinique de l'Espérance, CHC, Liège, Belgium.
  • Norga K; Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Gilotay C; Pediatric Onco-Hematology Unit, Antwerp University Hospital, Antwerp, Belgium.
  • Rohrlich PS; EORTC Headquarters, Brussels, Belgium.
  • Benoit Y; Department of Pediatric Onco-Hematology, Nice University Hospital, Nice, France.
  • Cavé H; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
Leukemia ; 32(1): 244-248, 2018 01.
Article em En | MEDLINE | ID: mdl-29064485

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas Proto-Oncogênicas c-ets / Subunidade alfa 2 de Fator de Ligação ao Core / Antineoplásicos Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas Proto-Oncogênicas c-ets / Subunidade alfa 2 de Fator de Ligação ao Core / Antineoplásicos Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article